Developer docs
API playgroundTry for free, no card

Search company profiles

CardioNet

Full company profile

uuid003ecld

Namestring
CardioNet
Legal namestring
CardioNet
Websiteurl
cardionet.com
Company typeenum
Private
Founded yearint
1999
Descriptiontext

CardioNet provides real-time ambulatory outpatient cardiac monitoring and diagnostic solutions, operating today as a subsidiary within Philips Healthcare's Ambulatory Monitoring and Diagnostics division (formerly BioTelemetry). The company's core technology stack comprises three flagship product lines: Mobile Cardiac Telemetry (MCOT), which delivers real-time continuous wireless ECG transmission for proactive patient management outside hospital settings; the Extended Holter (ePatch) for long-term continuous ECG monitoring; and Remote INR monitoring for at-home blood coagulation testing in warfarin patients. EMR integration capabilities are layered across these products to feed monitoring data directly into provider electronic medical record systems.

Revenue is generated through a subscription and per-test service billing model, with B2B contracts sold to healthcare systems, hospitals, cardiology and electrophysiology practices, and primary care providers. The go-to-market motion is enterprise field sales, executed primarily through Philips' global healthcare distribution network, complemented by a direct patient portal (myheartmonitor.com) that enables self-service access for individual consumers. The business is positioned within Philips as the "#1 patient care management ecosystem," integrating in-hospital diagnostic cardiology with at-home ambulatory monitoring across stroke, ED discharge, and primary care clinical pathways.

The business model combines recurring monitoring service contracts with diagnostic test billing, supported by AI-powered analytics (automated triage and predictive analytics) that target reductions in provider alert fatigue. Geographic reach is global via Philips' North America, Europe, and Asia distribution infrastructure. The headcount is 501-1,000 employees, anchored at headquarters in the Philadelphia / Conshohocken, PA area. CardioNet's competitive moat rests heavily on Philips' distribution scale, regulatory-cleared medical device status, embedded EMR integrations that create switching costs, and accumulated proprietary ECG datasets feeding continuous analytics.

Short descriptiontext

CardioNet provides real-time ambulatory cardiac monitoring and diagnostic solutions, including Mobile Cardiac Telemetry, Extended Holter, and Remote INR monitoring, serving hospitals, cardiology practices, and primary care providers through Philips Healthcare's global distribution network.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
501–1,000
akta.pro rankint
HeadquartersConshohocken, United States
HQ citystring
Conshohocken
HQ countrystring
United States
HQ regionstring
North America
Markets served

Serves global market

Offices1 record

Each record includes

City, Country, Type, Description, Source

Keyword5 values
remote cardiac monitoring, ambulatory ECG services, mobile cardiac telemetry, Holter monitoring devices, remote patient monitoring
Industry3 codes
1Cardiac Monitoring (ECG/Holter/Event/Patch, Loop Recorders)
CodeHLAHACABPrimaryYes
2Cardiometabolic RPM & Chronic Disease Management (diabetes, hypertension, CHF, obesity)
CodeHLALAFAAPrimaryNo
3Electrophysiology (Heart Rhythm)
CodeHLAKABACPrimaryNo
NAICS code2 codes
  • Outpatient Care Centers6214
  • Ambulatory Health Care Services621
SIC code2 codes
  • Electromedical & Electrotherapeutic Apparatus3845
  • Services-Specialty Outpatient Facilities, Nec8093
Product category
Remote Cardiac Monitoring Services
GTM motion1 record

Each record includes

Type, Description, Source

Revenue model1 record
1Remote Patient Monitoring Services
TypeSubscription Recurring
Description

CardioNet provides remote cardiac monitoring services to healthcare providers and health systems. Revenue is generated through healthcare service contracts, device rental/subscription models, and per-test billing for diagnostic monitoring services.

murphi.ai
Marketing channels3 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels3 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components6 values
Personnel, Technology or R&D, Operations, Marketing or Sales, Infrastructure, Supply Chain
GTM typeB2B
B2B
Offering typeServices
Services
Core offering1 text field

CardioNet provides real-time ambulatory outpatient cardiac monitoring solutions, delivering continuous ECG data and diagnostic services outside hospital settings. Its core offerings include Mobile Cardiac Telemetry (MCOT), Extended Holter monitoring via the ePatch device, and Remote INR monitoring for warfarin patients, all integrated with provider EMR systems to support arrhythmia detection, stroke prevention, and proactive cardiac patient management.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 value
  • Reduction in provider alert fatigue by up to 87% through AI-powered automated triage systems
Product overview1 text field

CardioNet is referenced in industry context as one of the top remote patient monitoring companies, offering cardiac monitoring solutions. However, no specific CardioNet-branded products, services, or technical details are available in the provided source data. The related Philips/BioTelemetry ambulatory monitoring solutions include Mobile Cardiac Telemetry (MCOT), Extended Holter (ePatch), and Remote INR monitoring, but these are not attributed to CardioNet specifically.

Product and service4 records
1Mobile Cardiac Telemetry (MCOT)
CategoryRemote Cardiac Monitoring Services
Description

Real-time continuous cardiac monitoring service with wireless transmission of ECG data for proactive patient management outside hospital settings. Designed for healthcare providers including hospitals, cardiology practices, and primary care for arrhythmia detection and post-discharge cardiac monitoring.

2Extended Holter (ePatch)
CategoryAmbulatory ECG Monitoring Services
Description

Long-term continuous ECG monitoring service via a miniaturized patch device for extended cardiac assessment beyond traditional Holter monitoring periods. Targets cardiology and electrophysiology practices requiring diagnostic-grade continuous ECG data.

3Remote INR Monitoring
CategoryRemote Patient Monitoring Services
Description

Remote international normalized ratio (INR) testing service for patients on warfarin therapy, enabling at-home blood coagulation monitoring. Designed for cardiology and primary care providers managing anticoagulation patients.

4EMR Integration
CategoryHealthcare IT Integration
Description

Integration offering that connects CardioNet cardiac monitoring devices and data with hospital and practice electronic medical record systems for seamless workflow and data flow. Designed for healthcare enterprises seeking interoperability between ambulatory monitoring outputs and clinical systems.

Scale indicator3 records

Each record includes

Type, Value, Description, Source

Partnership2 partners
Strategic tierCoreTypeStrategic or Co-development Partner
Description

CardioNet operates as a subsidiary of Philips Healthcare following the acquisition of BioTelemetry by Philips. This combination creates the #1 patient care management ecosystem, integrating Philips' hospital solutions with CardioNet's home monitoring capabilities.

Strategic tierMinorTypeOthers
Description

Philips works with Giving it Back to Kids, a non-profit organization in Southeast Asia that provides life-saving surgeries and medical care for children with heart disease. CardioNet cardiac monitoring solutions support this charitable initiative.

Recent move6 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight4 records

Each record includes

Type, Description

Peers10 records
TypeBroad incumbent
Description

CardioNet's parent company and broader healthcare technology incumbent offering in-hospital diagnostic cardiology, ECG, and patient monitoring solutions that compete in adjacent but overlapping categories.

TypeOthers
Description

Consumer wearable incumbent (Apple Watch) with FDA-cleared ECG and AFib detection features at massive installed base. Adjacent ecosystem participant increasingly competing for atrial fibrillation screening at the consumer/primary care interface.

TypeDirect peer
Description

Clinical ambulatory cardiac monitoring company best known for the Zio patch. Competes directly with CardioNet's MCOT and ePatch Holter products for cardiology practice and hospital enterprise contracts.

TypeBroad incumbent
Description

Japanese medical electronics company offering Holter monitors, ECG systems, and ambulatory cardiac monitoring devices. Comparable product portfolio and enterprise healthcare channel overlap with CardioNet's Holter/MCOT line.

TypeBroad incumbent
Description

Global medtech incumbent with cardiac rhythm management, insertable cardiac monitors (LINQ), and remote monitoring services. Competes in ambulatory and implantable cardiac monitoring across overlapping hospital and electrophysiology customers.

TypeBroad incumbent
Description

Major cardiology device incumbent with rhythm management and remote monitoring (formerly Preventice BodyGuardian). Provides overlapping ambulatory cardiac telemetry and Holter offerings to the same hospital and cardiology channels.

TypeEmerging player
Description

Emerging cardiac wearable/remote monitoring company focused on sleep-apnea and cardiac arrhythmia detection. Comparable technology approach in remote cardiac diagnostics through miniaturized wearables.

TypeEmerging player
Description

Consumer and clinical ECG company with KardiaMobile devices offering single-lead ECG and AFib detection. An emerging adjacent player in cardiac monitoring intersecting the lower-acuity end of CardioNet's screening market.

TypeBroad incumbent
Description

Diagnostic cardiology and patient monitoring incumbent with resting ECG, Holter, and hospital telemetry solutions. Competes with CardioNet for the same cardiology and hospital system buyers.

TypeBroad incumbent
Description

Cardiovascular franchise including insertable cardiac monitors (Confirm Rx, Jot Dx) and remote monitoring. Competes with CardioNet in electrophysiology and AFib detection across hospitals and cardiology practices.

Market position
Strengths4 records

Each record includes

Headline, Details, Source

Weaknesses4 records

Each record includes

Headline, Details, Source

Competitive moat5 records

Each record includes

Type, Details

Key risks5 records

Each record includes

Headline, Details, Source

Key highlights6 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers3 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment3 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile3 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Feature4 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles6 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds4 records

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors7 records

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A2 records

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

CardioNet

Remote Cardiac Monitoring Servicescardionet.com

CardioNet provides real-time ambulatory cardiac monitoring and diagnostic solutions, including Mobile Cardiac Telemetry, Extended Holter, and Remote INR monitoring, serving hospitals, cardiology practices, and primary care providers through Philips Healthcare's global distribution network.

What CardioNet does

CardioNet provides real-time ambulatory outpatient cardiac monitoring and diagnostic solutions, operating today as a subsidiary within Philips Healthcare's Ambulatory Monitoring and Diagnostics division (formerly BioTelemetry). The company's core technology stack comprises three flagship product lines: Mobile Cardiac Telemetry (MCOT), which delivers real-time continuous wireless ECG transmission for proactive patient management outside hospital settings; the Extended Holter (ePatch) for long-term continuous ECG monitoring; and Remote INR monitoring for at-home blood coagulation testing in warfarin patients. EMR integration capabilities are layered across these products to feed monitoring data directly into provider electronic medical record systems.

Revenue is generated through a subscription and per-test service billing model, with B2B contracts sold to healthcare systems, hospitals, cardiology and electrophysiology practices, and primary care providers. The go-to-market motion is enterprise field sales, executed primarily through Philips' global healthcare distribution network, complemented by a direct patient portal (myheartmonitor.com) that enables self-service access for individual consumers. The business is positioned within Philips as the "#1 patient care management ecosystem," integrating in-hospital diagnostic cardiology with at-home ambulatory monitoring across stroke, ED discharge, and primary care clinical pathways.

The business model combines recurring monitoring service contracts with diagnostic test billing, supported by AI-powered analytics (automated triage and predictive analytics) that target reductions in provider alert fatigue. Geographic reach is global via Philips' North America, Europe, and Asia distribution infrastructure. The headcount is 501-1,000 employees, anchored at headquarters in the Philadelphia / Conshohocken, PA area. CardioNet's competitive moat rests heavily on Philips' distribution scale, regulatory-cleared medical device status, embedded EMR integrations that create switching costs, and accumulated proprietary ECG datasets feeding continuous analytics.

CardioNet firmographics

Firmographics
Name
CardioNet
Legal name
CardioNet
Website
https://cardionet.com
Company type
Private
Founded year
1999
Operating status
Operating
Headcount range
501–1,000 employees
Short description
CardioNet provides real-time ambulatory cardiac monitoring and diagnostic solutions, including Mobile Cardiac Telemetry, Extended Holter, and Remote INR monitoring, serving hospitals, cardiology practices, and primary care providers through Philips Healthcare's global distribution network.
Ownership category
akta.pro rank

CardioNet industry classification

Industry
Product category
Remote Cardiac Monitoring Services
NAICS
Outpatient Care Centers (6214), Ambulatory Health Care Services (621)
SIC
Electromedical & Electrotherapeutic Apparatus (3845), Services-Specialty Outpatient Facilities, Nec (8093)
akta.pro primary industry
Cardiac Monitoring (ECG/Holter/Event/Patch, Loop Recorders) (HLAHACAB)
akta.pro secondary industries
Cardiometabolic RPM & Chronic Disease Management (diabetes, hypertension, CHF, obesity) (HLALAFAA), Electrophysiology (Heart Rhythm) (HLAKABAC)

Keywords

  • Remote cardiac monitoring
  • Ambulatory ECG services
  • Mobile cardiac telemetry
  • Holter monitoring devices
  • Remote patient monitoring

Where CardioNet is headquartered

Location

Headquarters

HQ city
Conshohocken
HQ country
United States
HQ region
North America

Offices1 record

Markets served

CardioNet business model

Business model
GTM type
B2B
Offering type
Services
Cost components
Personnel, Technology or R&D, Operations, Marketing or Sales, Infrastructure, Supply Chain

Revenue model

  1. Remote Patient Monitoring Services: CardioNet provides remote cardiac monitoring services to healthcare providers and health systems. Revenue is generated through healthcare service contracts, device rental/subscription models, and per-test billing for diagnostic monitoring services.

Go-to-market motion1 record

Distribution channels3 records

Marketing channels3 records

CardioNet product offering

Product offering

Core offering

CardioNet provides real-time ambulatory outpatient cardiac monitoring solutions, delivering continuous ECG data and diagnostic services outside hospital settings. Its core offerings include Mobile Cardiac Telemetry (MCOT), Extended Holter monitoring via the ePatch device, and Remote INR monitoring for warfarin patients, all integrated with provider EMR systems to support arrhythmia detection, stroke prevention, and proactive cardiac patient management.

Product overview

CardioNet is referenced in industry context as one of the top remote patient monitoring companies, offering cardiac monitoring solutions. However, no specific CardioNet-branded products, services, or technical details are available in the provided source data. The related Philips/BioTelemetry ambulatory monitoring solutions include Mobile Cardiac Telemetry (MCOT), Extended Holter (ePatch), and Remote INR monitoring, but these are not attributed to CardioNet specifically.

Differentiator

Problem solved

Functional benefit

Products and services

  • Mobile Cardiac Telemetry (MCOT) Real-time continuous cardiac monitoring service with wireless transmission of ECG data for proactive patient management outside hospital settings. Designed for healthcare providers including hospitals, cardiology practices, and primary care for arrhythmia detection and post-discharge cardiac monitoring.
  • Extended Holter (ePatch) Long-term continuous ECG monitoring service via a miniaturized patch device for extended cardiac assessment beyond traditional Holter monitoring periods. Targets cardiology and electrophysiology practices requiring diagnostic-grade continuous ECG data.
  • Remote INR Monitoring Remote international normalized ratio (INR) testing service for patients on warfarin therapy, enabling at-home blood coagulation monitoring. Designed for cardiology and primary care providers managing anticoagulation patients.
  • EMR Integration Integration offering that connects CardioNet cardiac monitoring devices and data with hospital and practice electronic medical record systems for seamless workflow and data flow. Designed for healthcare enterprises seeking interoperability between ambulatory monitoring outputs and clinical systems.

Quantifiable outcome

  • Reduction in provider alert fatigue by up to 87% through AI-powered automated triage systems

Companies that use CardioNet

Customer profile

Named customers3 records

Segments3 records

Ideal customer profiles3 records

CardioNet technology and API

Technology

Technology focussed Yes

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Feature4 records

CardioNet partnerships and signals

Strategic signal

Partnerships

Two partnerships are on record, tiered core and minor.

  • Philips Healthcare (Parent Company)coreStrategic or Co-development PartnerCardioNet operates as a subsidiary of Philips Healthcare following the acquisition of BioTelemetry by Philips. This combination creates the #1 patient care management ecosystem, integrating Philips' hospital solutions with CardioNet's home monitoring capabilities.
  • Giving it Back to KidsminorOthersPhilips works with Giving it Back to Kids, a non-profit organization in Southeast Asia that provides life-saving surgeries and medical care for children with heart disease. CardioNet cardiac monitoring solutions support this charitable initiative.

Scale indicators3 records

Recent moves6 records

Expansion highlights4 records

CardioNet competitors and assessment

Company assessment

Broad incumbents

  • Koninklijke Philips (Philips Healthcare): CardioNet's parent company and broader healthcare technology incumbent offering in-hospital diagnostic cardiology, ECG, and patient monitoring solutions that compete in adjacent but overlapping categories.
  • Nihon Kohden: Japanese medical electronics company offering Holter monitors, ECG systems, and ambulatory cardiac monitoring devices. Comparable product portfolio and enterprise healthcare channel overlap with CardioNet's Holter/MCOT line.
  • Medtronic: Global medtech incumbent with cardiac rhythm management, insertable cardiac monitors (LINQ), and remote monitoring services. Competes in ambulatory and implantable cardiac monitoring across overlapping hospital and electrophysiology customers.
  • Boston Scientific: Major cardiology device incumbent with rhythm management and remote monitoring (formerly Preventice BodyGuardian). Provides overlapping ambulatory cardiac telemetry and Holter offerings to the same hospital and cardiology channels.
  • GE HealthCare: Diagnostic cardiology and patient monitoring incumbent with resting ECG, Holter, and hospital telemetry solutions. Competes with CardioNet for the same cardiology and hospital system buyers.
  • Abbott: Cardiovascular franchise including insertable cardiac monitors (Confirm Rx, Jot Dx) and remote monitoring. Competes with CardioNet in electrophysiology and AFib detection across hospitals and cardiology practices.

Others

  • Apple: Consumer wearable incumbent (Apple Watch) with FDA-cleared ECG and AFib detection features at massive installed base. Adjacent ecosystem participant increasingly competing for atrial fibrillation screening at the consumer/primary care interface.

Direct peers

  • iRhythm Technologies: Clinical ambulatory cardiac monitoring company best known for the Zio patch. Competes directly with CardioNet's MCOT and ePatch Holter products for cardiology practice and hospital enterprise contracts.

Emerging players

  • Huxley Medical: Emerging cardiac wearable/remote monitoring company focused on sleep-apnea and cardiac arrhythmia detection. Comparable technology approach in remote cardiac diagnostics through miniaturized wearables.
  • AliveCor: Consumer and clinical ECG company with KardiaMobile devices offering single-lead ECG and AFib detection. An emerging adjacent player in cardiac monitoring intersecting the lower-acuity end of CardioNet's screening market.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat5 records

Key risks5 records

Key highlights6 records

Customer concentration

CardioNet social profiles

Digital presence

CardioNet financial estimates

Financial estimate

Revenue estimate

Valuation estimate

CardioNet leadership team

Management profile

Number of profiles

Profiles6 records

CardioNet funding detail

Funding detail

Funding overview

Funding rounds4 records

Investors7 records

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

CardioNet M&A and investment

M&A and investment

M&A2 records

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about CardioNet

What does CardioNet do?

CardioNet provides real-time ambulatory outpatient cardiac monitoring solutions, delivering continuous ECG data and diagnostic services outside hospital settings. Its core offerings include Mobile Cardiac Telemetry (MCOT), Extended Holter monitoring via the ePatch device, and Remote INR monitoring for warfarin patients, all integrated with provider EMR systems to support arrhythmia detection, stroke prevention, and proactive cardiac patient management.

Is CardioNet a public or private company?

CardioNet is a private company. It is classified as corporate owned and is currently operating.

When was CardioNet founded?

CardioNet was founded in 1999. It employs 501 to 1,000 people.

Where is CardioNet based?

CardioNet is headquartered in Conshohocken, United States, in the North America region.

How does CardioNet make money?

One revenue line is on record: remote Patient Monitoring Services.

Who are CardioNet's main competitors?

Broad incumbents on record are Koninklijke Philips (Philips Healthcare), Nihon Kohden, Medtronic, Boston Scientific, GE HealthCare and Abbott. Apple is listed as an others. iRhythm Technologies is listed as a direct peer. Emerging players are Huxley Medical and AliveCor.

Does CardioNet have an API?

No public API is recorded for CardioNet.

What industry is CardioNet in?

CardioNet's product category is Remote Cardiac Monitoring Services. Its primary akta.pro industry code is HLAHACAB, Cardiac Monitoring (ECG/Holter/Event/Patch, Loop Recorders), with a secondary code of HLALAFAA, Cardiometabolic RPM & Chronic Disease Management (diabetes, hypertension, CHF, obesity). Its NAICS code is 6214 and its SIC code is 3845.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
GlobeNewswireLifeWatch’s Largest Shareholders Accept BioTelemetry, Inc.’s Tender Offer for LifeWatch AGBioTelemetry announced a tender offer for LifeWatch AG, with major shareholders pledging support and agreeing to tender shares. The offer provides CHF10 cash plus 0.1617 BioTelemetry shares per LifeWatch share, totaling about CHF269 million. The main offer period ends June 8, 2017, with an extension expected to June 28.GlobeNewswireBioTelemetry, Inc. Announces Receipt of Antitrust Clearance for its Acquisition of LifeWatch AGBioTelemetry received early termination of the HSR waiting period for its tender offer to acquire LifeWatch AG, effective May 5, 2017, without conditions. The transaction is expected to close in the third quarter of 2017, subject to other closing conditions.GlobeNewswireBioTelemetry, Inc. Announces Its Latest Success in Patent EnforcementBioTelemetry announced a District Court consent judgment permanently enjoining InfoBionic from using its First-Generation MoMe Kardia system. The court entered the judgment on July 14, 2016, and BioTelemetry has pending claims against InfoBionic's Second-Generation system and trade secret misappropriation.PR NewswireResearch and Markets - Global ECG Equipment Market Growth of 6.1% CAGR by 2021 - Trends, Technologies & Opportunities Report 2016-2021 - Key Vendors: Schiller, GE Healthcare, CardionetResearch and Markets has released a comprehensive report on the global ECG equipment market, estimating it will reach $6,120 million by 2021 at a compound annual growth rate of 6.1% during 2015-2021.GlobeNewswireBioTelemetry, Inc. Announces the Completion of Its Acquisition of VirtualScopics, Inc.BioTelemetry completed its acquisition of VirtualScopics, a clinical trial imaging provider, after an all-cash tender offer. The purchase consideration was approximately $15.0 million, net of cash and debt acquired. The company will disclose the impact on 2016 results at its Q2 earnings call in late July.GlobeNewswireBioTelemetry, Inc. Signs Definitive Agreement to Acquire VirtualScopics, Inc.BioTelemetry agreed to acquire VirtualScopics in an all-cash tender offer, offering $4.05 per common share and up to $920 per preferred share, for about $15.5 million. The tender offer is expected to start April 11, 2016, with closing in Q2 2016. VirtualScopics reported 2015 revenue of $12.7 million.GlobeNewswireBioTelemetry, Inc. Reports Fourth Quarter and Full Year 2015 Financial ResultsBioTelemetry reported Q4 2015 revenue of $46.8 million and full-year revenue of $178.5 million, both up year-over-year. The company posted record EBITDA of $10.1 million for Q4 and $33.0 million for the year, with full-year net income of $7.4 million. It expects low double-digit revenue growth and a 20% adjusted EBITDA margin in 2016.GlobeNewswireBioTelemetry, Inc. Reports First Quarter 2015 Financial ResultsBioTelemetry reported Q1 2015 revenue of $43.4 million, up 17% year over year, and adjusted EBITDA of $6.4 million, more than double the prior year. Patient volume grew 29% to over 140,000, and the company expects to achieve full-year 2015 profitability.GlobeNewswireBioTelemetry, Inc. to Release First Quarter 2015 Earnings Results on May 6, 2015BioTelemetry, Inc. will release its first quarter 2015 earnings on May 6, 2015, at 4:00 PM Eastern Time, with a conference call at 5:00 PM. The broadcast will be available on the company's website, with an archive for two weeks.GlobeNewswireBioTelemetry, Inc. Announces That Eric Prystowsky M.D. Will Transition From the Board of Directors Into a Medical Advisory RoleBioTelemetry announced that Eric Prystowsky M.D. will transition from board director to medical advisor after 13 years of service. He will enter a multi-year agreement as advisor, and CEO Joseph Capper praised his contributions. The company expects to continue benefiting from his perspective on wireless medicine.